RIPK1 and celiac disease: Additionally, this study reveals how intestinal T cell perturbation through RIPK1 ablation can result in specific pathological features observed in human enteropathies, such as celiac disease, autoimmune enteropathy and Crohn’s disease (Vyhlidal et al, 2021; Lebwohl et al, 2018; Gentile et al, 2012).